CYBREXA THERAPEUTICS

Cybrexa Therapeutics is developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale. Our approach will change the paradigm of drug delivery, and it will greatly enhance the therapeutic index. It has the potential to re-define the definition of “drug-like,” which will unlock a vast array of molecules for clinical development. Our collection of tumor-localizing DNA repair inhibitors can be combined with numerous chemotherapies and also radiotherapy, allowing the safe delivery of higher drug doses, with enhanced efficacy.

#SimilarOrganizations #People #Financial #Website #More

CYBREXA THERAPEUTICS

Social Links:

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2017-01-01

Address:

New Haven, Connecticut, United States

Country:

United States

Website Url:

http://www.cybrexa.com

Total Employee:

Status:

Active

Contact:

+1 860 717 2731

Total Funding:

44.4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

remedy-plan-therapeutics-logo

Remedy Plan Therapeutics

Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.

Current Advisors List

kevin-rakin_image

Kevin Rakin Board Chairman @ Cybrexa Therapeutics
Board_member

not_available_image

Kevin Didden Board Chairman @ Cybrexa Therapeutics
Board_member

Current Employees Featured

ranjit-s-bindra_image

Ranjit S. Bindra
Ranjit S. Bindra Co-founder and Chief Scientific Advisor @ Cybrexa Therapeutics
Co-founder and Chief Scientific Advisor
2017-01-01

dr-peter-glazer-md-phd_image

Dr. Peter Glazer, MD, PhD
Dr. Peter Glazer, MD, PhD CMA @ Cybrexa Therapeutics
CMA

per-hellsund_image

Per Hellsund
Per Hellsund President and CEO @ Cybrexa Therapeutics
President and CEO
2017-01-01

Founder

per-hellsund_image

Per Hellsund

Investors List

elm-street-ventures_image

Official Site Inspections

http://www.cybrexa.com

Host Informations
Whois Informations

Loading ...